港股午評:三大指數齊升 生物醫藥股大幅走高 SaaS概念股繼續活躍
港股上午盤三大指數小幅下探後拉昇回暖,恒指、國指分別上升0.42%及0.37%,恒生科技指數升0.82%,市場情緒止跌回升。盤面上,大型科技股普遍上升,美團、京東升超2%,網易升超1%,小米、騰訊、阿里巴巴、百度皆有升幅,快手逆勢微跌;國家醫保藥品目錄揭榜在即,生物醫藥股全線走高,諾誠健華升超8%領銜;SaaS概念股繼續表現活躍,醫渡科技大升近13%並錄得3連升;國產替代前景廣闊,半導體股普遍上升,龍頭中芯國際升超1%;中期內地盈利大增,維他奶飆升超26%領銜乳業股上升;光伏股、手遊股、家電股、電信股多數上升。另一方面,餐飲股等消費股走低,鋰電池股、汽車股、教育股多數表現低迷,蔚來跌近5%,在線教育龍頭新東方跌1.6%,汽車街放量暴跌44%,禁售期今日屆滿。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.